抗IgLON5病中运动障碍的频率与特征
这项回顾性观察研究纳入72例抗IgLON5病患者,通过标准化临床问卷和视频专家评审评估运动障碍。87%患者至少有一种运动障碍,中位数为3种,步态平衡障碍最常见(72%),免疫治疗仅13%获得持续改善。
要点
- 抗IgLON5病患者中运动障碍常见,87%至少有一种,中位3种。
- 步态平衡障碍最常见(72%),其次为舞蹈症、运动迟缓、肌张力障碍。
- 多运动障碍合并睡眠改变、球部功能障碍或认知障碍时应考虑该病。
核心结论
- 运动障碍是抗IgLON5病患者常见的首发就诊原因,且表现多样。
研究设计与样本
- 回顾性观察研究,纳入72例连续抗IgLON5病患者,采用标准化临床问卷评估运动障碍,可用视频由3位运动障碍专家集中评审。
主要发现
- 41例(57%)患者以行走困难伴一种或多种运动障碍为主要首诊原因。
- 诊断时63例(87%)患者至少有一种运动障碍,中位数为每人3种。
- 最常见的异常运动为步态和平衡障碍(52例[72%])、舞蹈症(24例[33%])、运动迟缓(20例[28%])、肌张力障碍(19例[26%])、异常身体姿势或强直(18例[25%])和震颤(15例[21%])。
- 其他多动性运动(肌阵挛、静坐不能、肌律、肌纤维颤搐或腹部运动障碍)见于26例(36%)患者。
- 颅面部区域常受多种并发运动障碍影响(23例[32%]),包括肌张力障碍(13例)、肌律(6例)、舞蹈症(4例)或肌纤维颤搐(4例)。
关键数值与推荐
- 任何身体区域中,最常见的多运动障碍组合为步态不稳或共济失调伴颅面部运动障碍或全身性舞蹈症,见于31例(43%)患者。
- 除异常运动外,87%患者有睡眠改变,74%有球部功能障碍,53%有认知障碍。
临床怎么用
- 对表现多种运动障碍,尤其合并睡眠改变、球部功能障碍或认知障碍的患者,应考虑抗IgLON5病。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Anti-IgLON5 disease is a recently described neurologic disease that shares features of autoimmunity and neurodegeneration. Abnormal movements appear to be frequent and important but have not been characterized and are underreported. We describe the frequency and types of movement disorders in a series of consecutive patients with this disease. METHODS: In this retrospective, observational study, the presence and phenomenology of movement disorders were assessed with a standardized clinical questionnaire. Available videos were centrally reviewed by 3 experts in movement disorders. RESULTS: Seventy-two patients were included. In 41 (57%), the main reason for initial consultation was difficulty walking along with one or several concurrent movement disorders. At the time of anti-IgLON5 diagnosis, 63 (87%) patients had at least 1 movement disorder with a median of 3 per patient. The most frequent abnormal movements were gait and balance disturbances (52 patients [72%]), chorea (24 [33%]), bradykinesia (20 [28%]), dystonia (19 [26%]), abnormal body postures or rigidity (18 [25%]), and tremor (15 [21%]). Other hyperkinetic movements (myoclonus, akathisia, myorhythmia, myokymia, or abdominal dyskinesias) occurred in 26 (36%) patients. The craniofacial region was one of the most frequently affected by multiple concurrent movement disorders (23 patients [32%]) including dystonia (13), myorhythmia (6), chorea (4), or myokymia (4). Considering any body region, the most frequent combination of multiple movement disorders consisted of gait instability or ataxia associated with craniofacial dyskinesias or generalized chorea observed in 31 (43%) patients. In addition to abnormal movements, 87% of patients had sleep alterations, 74% bulbar dysfunction, and 53% cognitive impairment. Fifty-five (76%) patients were treated with immunotherapy, resulting in important and sustained improvement of the movement disorders in only 7 (13%) cases. DISCUSSION: Movement disorders are a frequent and leading cause of initial neurologic consultation in patients with anti-IgLON5 disease. Although multiple types of abnormal movements can occur, the most prevalent are disorders of gait, generalized chorea, and dystonia and other dyskinesias that frequently affect craniofacial muscles. Overall, anti-IgLON5 disease should be considered in patients with multiple movement disorders, particularly if they occur in association with sleep alterations, bulbar dysfunction, or cognitive impairment.
引用
- Gaig C, Compta Y, Heidbreder A, et al. Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease. Neurology. 2021. PMID: 34380749. doi:10.1212/WNL.0000000000012639
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。